Captozyme

About:

Captozyme is a biotechnology company focused on therapeutic enzyme-based products for health and wellness.

Description:

Biotechnology company dedicated to helping people better manage their diets and overall health. The company plans to launch Nephure in the spring of 2017. With Nephure the company has created a product that allows people to enjoy the foods they love without the consequences of adding oxalate to their bodies.

Total Funding Amount:

$3.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gainesville, Florida, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)captozyme.com

Founders:

Aaron Cowley, Qingshan Li

Number of Employees:

11-50

Last Funding Date:

2017-03-15

IPO Status:

Private

Industries: